Longevity peptides are short signaling molecules studied for mitochondrial efficiency, cellular senescence pathways, and metabolic resilience across age-related research.
Longevity
All products listed under this goal are supplied for in vitro laboratory research only and are not intended for human consumption or therapeutic use.
Peptides for the long game — chosen for people thinking years ahead.
Peptides chosen for people thinking in decades — each with clear science, visible testing, and honest guidance on expectations.
- Which peptide is a sensible starting point for longevity?
- What research supports these choices?
- How are the peptides tested and handled before shipping?
A short list of peptides that fit this goal.
We keep the choice focused. Every peptide here has a clear purpose, ISO/IEC 17025 lab testing, and a product page written without jargon.

Nicotinamide adenine dinucleotide — a coenzyme central to cellular energy metabolism and sirtuin-pathway signalling, studied for its role in longevity and mitochondrial health.

Endocrinology & Cellular Regeneration Research.

A tetrapeptide studied for its role in supporting telomerase activity and circadian rhythm — framed for long-horizon routines.

A mitochondria-derived peptide studied for its role in metabolic regulation, insulin sensitivity, and cellular energy homeostasis — an emerging longevity-pathway molecule.
- cellular-maintenance
- protocol-clarity
Each release is matched with quality documentation through a documented verification path. Identity, purity, and composition test results sit on the product page before you buy.
Every batch is verified by an ISO/IEC 17025-accredited laboratory before release. Identity, purity, and documentation travel with the product — not behind a form.
A research-literate guide for reading peptide claims: study type first, human relevance second, buying decision third.
NAD+ is not a peptide. It is a dinucleotide coenzyme central to sirtuin biology, DNA-damage repair, and cellular energy. This guide separates the published mechanism from the marketing.
Epitalon is a four-amino-acid peptide with striking telomerase and lifespan claims. The honest version separates cell and animal results from the human evidence, which is thin and comes largely from one St Petersburg research network.
MOTS-c is a peptide made from the mitochondrion's own DNA, with a clean mechanism in cells and striking results in mice. The human evidence is much thinner, and it is on the WADA Prohibited List.
SS-31 (elamipretide) binds cardiolipin on the inner mitochondrial membrane. In September 2025 it became the first FDA-approved mitochondria-targeted peptide — for one narrow, rare-disease indication. Peptyds does not sell it.
Pinealon is a synthetic tripeptide, Glu-Asp-Arg, from the same Khavinson "peptide bioregulator" family as epitalon. Its gene-expression claims, and almost all of its cell, animal and human evidence, come from one Saint Petersburg research network — and Peptyds does not sell it.
Questions people ask about this category.
Honest, short answers to the things most shoppers want to know before they buy.
Strictly, no — NAD+ (nicotinamide adenine dinucleotide) is a dinucleotide coenzyme, not a chain of amino acids. It is often grouped with peptide therapies in clinic menus because the delivery format (subcutaneous or IV) and the longevity-research framing overlap, but biochemically it is a different class of molecule.
Oral NAD+ is poorly absorbed intact, so most oral supplements use precursors — NR (nicotinamide riboside) or NMN (nicotinamide mononucleotide) — which the body converts to NAD+. Subcutaneous and IV NAD+ bypass first-pass metabolism and produce measurable plasma elevations in published pharmacokinetic work.
Honestly: it depends on the molecule. EMA-approved peptide drugs (semaglutide, tirzepatide, tesamorelin, thymalfasin in some jurisdictions) have multi-year safety datasets. Unapproved research peptides — BPC-157, TB-500, Melanotan II, Epithalon — have limited or no long-term human data.
Bring both the lyophilised vial and the bacteriostatic water to room temperature, equalise pressure with a sterile vented needle, then inject the solvent slowly down the side of the vial. Swirl gently — never shake — until clear, and refrigerate at 2–8 °C.
The calculation is peptide mass (mg) ÷ desired concentration (mg/mL) = volume of bacteriostatic water in mL. For example, a 5 mg vial at 1 mg/mL needs 5 mL; at 2 mg/mL, 2.5 mL. Every Peptyds product page carries a suggested reconstitution volume tuned to the vial size.